Literature DB >> 11263805

Use of simple and complex in vitro models for multiparameter characterization of human blood-material/device interactions.

K Münch1, M F Wolf, P Gruffaz, C Ottenwaelter, M Bergan, P Schroeder, E J Fogt.   

Abstract

Medical devices, intended for blood contacting applications, undergo extensive in vitro testing followed by animal and clinical feasibility studies. Besides the use of materials known to be intrinsically blood-compatible, the surface of such devices is often modified with a coating in order to improve the performance characteristics during blood exposure. In vitro evaluation of blood-device interactions accompanies the product development cycle from the early design phase using basic material geometries until final finished-product testing. Specific test strategies can vary significantly depending on the end application, the particular study objectives and variables of interest, and cost. To examine the degree to which findings derived from two different in vitro approaches complement one another, this report contrasts findings from a simple multipass loop model with findings from a simulated cardiopulmonary bypass (CPB) model. The loop model consists of tubular test materials, with and without surface modification, formed into valved Chandler loops. The CPB model has an oxygenator with and without surface modification connected to a reservoir and a blood pump. The surface modifications studied in this report are the Carmeda BioActive Surface and Duraflo II heparin coatings. Common blood parameters in the categories of coagulation, platelets, hematology, and immunology were monitored in each model. Ideal models employ the optimal level of complexity to study the design variables of interest and to meet practical cost considerations. In the case of medical device design studies, such models should also be predictive of performance. In the more complex and realistic simulated CPB model, experimental design and cost factors prevented easy/optimum manipulation of critical variables such as blood donor (use of paired samples) and heparin level. Testing in the simpler loop model, on the other hand, readily offered manipulation of these variables, and produced findings which overlapped with observations from the more complex CPB model. Thus, the models described here complimented one another. Moreover, conclusions from consistent findings, such as favorable responses associated with the heparin coatings, between the two models were considered to be more robust.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11263805     DOI: 10.1163/156856200744246

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  7 in total

Review 1.  Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.

Authors:  Terry C Major; Hitesh Handa; Gail M Annich; Robert H Bartlett
Journal:  J Biomater Appl       Date:  2014-06-16       Impact factor: 2.646

2.  Interactions of neutrophils with silver-coated vascular polyester grafts.

Authors:  Joerg Tautenhahn; Frank Meyer; Thomas Buerger; Uwe Schmidt; Hans Lippert; Wolfgang Koenig; Brigitte Koenig
Journal:  Langenbecks Arch Surg       Date:  2008-12-02       Impact factor: 3.445

3.  Comparison of modified chandler, roller pump, and ball valve circulation models for in vitro testing in high blood flow conditions: application in thrombogenicity testing of different materials for vascular applications.

Authors:  Wim van Oeveren; Ignace F Tielliu; Jurgen de Hart
Journal:  Int J Biomater       Date:  2012-05-09

4.  Thrombogenicity assessment of Pipeline, Pipeline Shield, Derivo and P64 flow diverters in an in vitro pulsatile flow human blood loop model.

Authors:  Gaurav Girdhar; Samantha Ubl; Reza Jahanbekam; Sinduja Thinamany; Anna Belu; John Wainwright; Michael F Wolf
Journal:  eNeurologicalSci       Date:  2019-01-08

Review 5.  Obstacles in haemocompatibility testing.

Authors:  W van Oeveren
Journal:  Scientifica (Cairo)       Date:  2013-05-07

6.  Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model.

Authors:  Gaurav Girdhar; Arielle Andersen; Elizabeth Pangerl; Reza Jahanbekam; Samantha Ubl; Kevin Nguyen; John Wainwright; Michael F Wolf
Journal:  J Biomed Mater Res A       Date:  2018-09-22       Impact factor: 4.396

7.  In vitro methodology for medical device material thrombogenicity assessments: A use condition and bioanalytical proof-of-concept approach.

Authors:  Michael F Wolf; Gaurav Girdhar; Arielle A Anderson; Samantha R Ubl; Sinduja Thinamany; Hannah N Jeffers; Courtney E DeRusha; Jenny Rodriguez-Fernandez; Sebastian Hoffmann; Carrie A Strief
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2020-09-14       Impact factor: 3.368

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.